SAB-185 potently neutralizes delta and lambda SARS-CoV-2 variants in nonclinical studies Aug. 12, 2021
Positive interim analysis data from phase II/III study of plonmarlimab in severe COVID-19 Aug. 12, 2021
Otsuka receives a grant for phase II study of OPC-167832 plus delamanid and bedaquiline Aug. 10, 2021
Enrollment ongoing in phase II study of USB-002 for respiratory distress due to COVID-19 Aug. 9, 2021
RSS